Central Glass (4044) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
21 Oct, 2026Executive summary
FY2023 net sales were ¥160.3bn, operating profit ¥14.5bn and ordinary profit ¥16.3bn; sales and operating profit declined YoY, while results exceeded the November forecast on profit.
FY2024 guidance projects lower sales and profits, with Glass sales growth offset by a forecast decline in Chemicals sales and operating profit.
Financial highlights
FY2023 net sales fell 5.3% YoY to ¥160.3bn; operating profit fell 13.3% to ¥14.5bn and ordinary profit fell 17.1% to ¥16.3bn.
Profit attributable to owners of parent was ¥12.5bn versus ¥42.5bn in FY2022; FY2023 EPS was ¥504 versus ¥1,222.
FY2023 results beat the November forecast by ¥3.5bn in operating profit, ¥4.3bn in ordinary profit and ¥2.5bn in parent-attributable profit; net sales were ¥1.2bn below forecast.
Outlook and guidance
FY2024 forecast: net sales ¥156.0bn, operating profit ¥11.0bn, ordinary profit ¥12.5bn and parent-attributable profit ¥10.0bn.
FY2024 operating margin is forecast at 7.1% versus 9.1% in FY2023; parent-attributable profit ratio is forecast at 6.4% versus 7.8%.
Forecast assumptions include ¥145/US$ exchange rate and crude oil at $79.0/bbl CIF, versus ¥141/US$ and $85.5/bbl in FY2023.
FY2024 net sales forecast: Glass ¥62.5bn, up ¥3.1bn; Chemicals ¥93.5bn, down ¥7.4bn, including a ¥11.4bn decline in Energy Materials.
Latest events from Central Glass
- New semiconductor materials support a ¥470億 FY2030 sales target.4044
Investor update - Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Sales fell 10.7%, but operating profit rose on LCM support; FY guidance was unchanged.4044
Q1 2024 - Weak demand cut nine-month results and FY2024 forecasts; the ¥170 dividend was maintained.4044
Q3 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - FY2025 sales edge higher, but operating profit falls amid weak demand and tariffs.4044
Q4 2024 - H1 operating profit fell 47.3% amid electrolyte pressure; FY2025 guidance was cut.4044
Q2 2025